adidas AG (NEO:ADI)

Verve Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 6, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	47,582	62,982	47,999	35,621	69,818	90,558
Market Cap Growth	-3.05%	31.22%	34.75%	-48.98%	-22.90%	9.44%
Enterprise Value	55,655	69,217	55,535	43,652	72,633	97,195
PE Ratio	24.71	55.34	-	40.24	22.93	134.49
PS Ratio	1.21	1.79	1.54	1.09	2.29	3.15
PB Ratio	5.35	7.21	6.68	4.60	6.19	8.68
P/TBV Ratio	8.32	11.20	11.34	7.46	8.17	13.69
P/FCF Ratio	36.90	16.97	15.04	-	17.98	51.97
P/OCF Ratio	24.23	14.53	12.90	-	15.20	39.10
EV/Sales Ratio	1.42	1.96	1.78	1.34	2.38	3.38
EV/EBITDA Ratio	11.73	25.08	48.46	24.88	20.09	52.31
EV/EBIT Ratio	19.37	35.12	135.87	44.25	25.30	84.15
EV/FCF Ratio	43.16	18.65	17.40	-	18.71	55.78
Debt / Equity Ratio	0.99	0.95	1.13	1.21	0.68	0.88
Debt / EBITDA Ratio	1.85	2.24	4.05	3.39	1.70	3.14
Debt / FCF Ratio	6.80	2.24	2.54	-	1.98	5.27
Asset Turnover	1.25	1.23	1.12	1.06	0.98	0.88
Inventory Turnover	2.44	2.45	2.14	2.38	2.49	2.17
Quick Ratio	0.45	0.59	0.55	0.48	0.77	0.76
Current Ratio	1.25	1.24	1.22	1.27	1.56	1.38
Return on Equity (ROE)	22.95%	15.27%	-1.13%	3.85%	20.54%	6.72%
Return on Assets (ROA)	5.74%	4.28%	0.91%	2.01%	5.77%	2.22%
Return on Capital (ROIC)	9.98%	7.54%	1.57%	3.41%	9.69%	3.79%
Return on Capital Employed (ROCE)	17.00%	12.00%	2.80%	6.20%	15.10%	6.10%
Earnings Yield	4.05%	1.81%	-0.23%	2.48%	4.36%	0.74%
FCF Yield	2.71%	5.89%	6.65%	-3.99%	5.56%	1.92%
Payout Ratio	29.70%	16.36%	-	99.67%	27.65%	-
Buyback Yield / Dilution	0.00%	-0.00%	2.57%	5.62%	0.50%	1.24%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.